Hims & Hers Faces Class Action Lawsuit Over Alleged Misrepresentations

NEW YORK, Sept. 30, 2026 /CourierPR/ -- Hims & Hers Health, Inc., a company listed on the New York Stock Exchange under the ticker symbol HIMS, has faced significant legal challenges following a class action lawsuit filed by Wolf Haldenstein Adler Freeman & Herz LLP. The lawsuit, which was initiated on behalf of investors who purchased the company’s securities between August 4, 2025, and July 29, 2026, alleges that Hims & Hers engaged in misleading practices and failed to disclose important information to its shareholders.

According to the complaint, Hims & Hers Health, Inc. was accused of sharing consumers' health information with third-party advertising platforms, charging consumers for prescriptions almost immediately after they submitted an intake form, despite representing that consumers would have the opportunity to consult with a medical provider to find a treatment that was "right for them." The company is also said to have created obstacles for consumers attempting to cancel subscriptions and misrepresented how their health information would remain private. The FTC, along with the People of the State of California through Los Angeles County Counsel, and the Utah Division of Consumer Protection, filed a lawsuit against Hims & Hers in the Northern District of California on July 29, 2026.

The lawsuit, which was announced following the company's stock price drop, revealed that the price of Hims & Hers stock fell $4.32 per share, or 14.73%, to close at $25.00 per share on the same day the lawsuit was filed. This significant decline in stock value reflects the financial impact of the allegations against the company.

Wolf Haldenstein Adler Freeman & Herz LLP, an illustrious firm founded in 1888, has over 125 years of legal expertise in securities litigation. The firm is committed to protecting the rights of investors who have suffered financial harm due to these misrepresented statements. The law firm encourages all investors who have been affected or who have information that will assist in the investigation to contact them immediately.

The class action lawsuit against Hims & Hers Health, Inc. highlights the ongoing scrutiny and legal challenges faced by the company in the wake of alleged misrepresentations and practices. The case underscores the importance of transparency and accurate disclosure in the healthcare industry, particularly in the digital health space where consumer trust is paramount.